CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ATTOAttovia Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $17.14 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$782.46M
RECENT INSIDER TRADES
  • 2026-08-10 · Deep Track Biotechnology Master Fund, Ltd. (10% Owner) · OTHER
  • 2026-08-10 · venBio Global Strategic Fund IV, L.P. (10% Owner) · OTHER
  • 2026-08-10 · venBio Global Strategic Fund IV, L.P. (10% Owner) · BUY
RECENT NEWS
  • Attovia Therapeutics to present pipeline data at EADV and dermatology conferences
  • Attovia Therapeutics presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS